Question

Genetic testing for BRCA or other hereditary breast cancer genes is not indicated in which of the following situations?

• A. Triple negative breast CA diagnosed $<60$ years
• B. 2 primary tumours in both breasts
• C. Male breast cancer
• D. $>50$year of age breast cancer

Hint:

Remember the clinical "Rule of 50" for genetic testing: A diagnosis of breast cancer at age $\leq 50$ years is a major trigger. Other absolute triggers include male gender, Ashkenazi Jewish ancestry, TNBC $\leq 60$ years, and bilateral cancers.

Answer 1

The Correct Option is D

Concept:
The question requires the clinician to apply the established, standard consensus guidelines (such as the NCCN guidelines) for initiating BRCA1/2 and comprehensive hereditary cancer genetic testing in patients diagnosed with breast cancer.
Genetic testing is costly and carries significant psychological and familial implications, so it is strictly reserved for patients presenting with personal or family histories that highly suggest a pathogenic underlying germline mutation.
Explanation:
• According to current oncological guidelines, genetic testing is strongly and unequivocally indicated for any male diagnosed with breast cancer at any age (Option C). Male breast cancer is exceptionally rare in the general population and is highly associated with underlying germline mutations, particularly BRCA2.

• Patients presenting with multiple primary breast cancers, such as synchronous or metachronous bilateral disease (Option B), are inherently at a high risk for carrying a genetic predisposition and require comprehensive testing.

• Women diagnosed with Triple-Negative Breast Cancer (TNBC) at age $\leq 60$ years (Option A) are strictly indicated for genetic testing. This is due to the remarkably strong and well-documented epidemiological association between early-onset TNBC and BRCA1 mutations.

• The age of onset is a critical determinant. Diagnosis of any breast cancer at age $\leq 50$ years is a major independent trigger for genetic screening.

• However, a single, isolated diagnosis of typical breast cancer (e.g., Hormone Receptor-positive) in a woman strictly over the age of 50, in the absolute absence of any other significant personal high-risk features or a strong family history, is statistically considered a sporadic event rather than a hereditary one. Thus, routine genetic testing is explicitly NOT indicated for this specific, low-risk demographic group.
Final Answer:
A routine diagnosis of breast cancer in a patient strictly over 50 years of age, without any other specific high-risk features, does not meet the criteria for hereditary genetic testing.